ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
A | ||
(State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) | |
(Address of Principal Executive Offices) |
Zip Code |
Title of Each Class |
Trading Symbol(s) |
Name of Each Exchange on Which Registered | ||
Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
Page | ||||||||
Cautionary Note Regarding Forward-Looking Statements And Risk Factor Summary | iii | |||||||
1 | ||||||||
1 | ||||||||
16 | ||||||||
49 | ||||||||
49 | ||||||||
49 | ||||||||
49 | ||||||||
50 | ||||||||
50 | ||||||||
51 | ||||||||
51 | ||||||||
55 | ||||||||
55 | ||||||||
55 | ||||||||
55 | ||||||||
56 | ||||||||
56 | ||||||||
57 | ||||||||
57 | ||||||||
65 | ||||||||
66 | ||||||||
69 | ||||||||
71 | ||||||||
72 | ||||||||
72 | ||||||||
73 | ||||||||
Index to Financial Statements | F-1 |
Item 1. |
Business |
• | subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination, and |
• | cause us to depend on the marketing and sale of a single product or limited number of products or services. |
• | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules, and |
• | file proxy materials with the SEC. |
• | conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers, and |
• | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
Item 1A. |
Risk Factors |
• | restrictions on the nature of our investments; and |
• | restrictions on the issuance of securities; |
• | registration as an investment company with the SEC; |
• | adoption of a specific form of corporate structure; and |
• | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations that we are currently not subject to. |
• | may significantly dilute the equity interest of investors in our initial public offering; |
• | may subordinate the rights of holders of Class A ordinary shares if preferred shares are issued with rights senior to those afforded our Class A ordinary shares; |
• | could cause a change in control if a substantial number of Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and |
• | may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants. |
• | solely dependent upon the performance of a single business, property or asset, or |
• | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
• | a limited availability of market quotations for our securities; |
• | reduced liquidity for our securities; |
• | a determination that our Class A ordinary shares are a “penny stock” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
• | a limited amount of news and analyst coverage; and |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand; |
• | our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding; |
• | our inability to pay dividends on our Class A ordinary shares; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
• | costs and difficulties inherent in managing cross-border business operations; |
• | rules and regulations regarding currency redemption; |
• | complex corporate withholding taxes on individuals; |
• | laws governing the manner in which future business combinations may be effected; |
• | exchange listing and/or delisting requirements; |
• | tariffs and trade barriers; |
• | regulations related to customs and import/export matters; |
• | local or regional economic policies and market conditions; |
• | unexpected changes in regulatory requirements; |
• | challenges in managing and staffing international operations; |
• | longer payment cycles; |
• | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
• | currency fluctuations and exchange controls; |
• | rates of inflation; |
• | challenges in collecting accounts receivable; |
• | cultural and language differences; |
• | employment regulations; |
• | underdeveloped or unpredictable legal or regulatory systems; |
• | corruption; |
• | protection of intellectual property; |
• | social unrest, crime, strikes, riots and civil disturbances; |
• | regime changes and political upheaval; |
• | terrorist attacks and wars; and |
• | deterioration of political relations with the United States. |
Item 1B. |
Unresolved Staff Comments |
Name |
Age |
Position | ||
Josh Bayliss |
48 | Chief Executive Officer and Director | ||
Evan Lovell |
52 | Chief Financial Officer and Director | ||
Rayhan Arif |
34 | Chief Operating Officer | ||
Latif Peracha |
41 | Director | ||
Elizabeth Nelson |
61 | Director | ||
Chris Burggraeve |
57 | Director |
• | assisting board oversight of (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements, (3) our independent registered public accounting firm’s qualifications and independence and (4) the performance of our internal audit function and independent auditors; the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us; |
• | pre-approving all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; |
• | reviewing and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence; |
• | setting clear policies for audit partner rotation in compliance with applicable laws and regulations; obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (1) the independent auditor’s internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; |
• | meeting to review and discuss our annual audited financial statements and quarterly financial statements with management and the independent auditor, including reviewing our specific disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; |
• | reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and |
• | reviewing with management, the independent auditors, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to our chief executive officer’s compensation; |
• | evaluating our chief executive officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our chief executive officer’s based on such evaluation; |
• | reviewing and making recommendations to our board of directors with respect to the compensation, and any incentive compensation and equity based plans that are subject to board approval of all of our other officers; |
• | reviewing our executive compensation policies and plans; |
• | implementing and administering our incentive compensation equity-based remuneration plans; |
• | assisting management in complying with our proxy statement and annual report disclosure requirements; |
• | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees; |
• | producing a report on executive compensation to be included in our annual proxy statement; and |
• | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
• | identifying, screening and reviewing individuals qualified to serve as directors, consistent with criteria approved by the board, and recommending to the board of directors candidates for nomination for appointment at the annual general meeting or to fill vacancies on the board of directors; |
• | developing and recommending to the board of directors and overseeing implementation of our corporate governance guidelines; |
• | coordinating and overseeing the annual self-evaluation of the board of directors, its committees, individual directors and management in the governance of the company; and |
• | reviewing on a regular basis our overall corporate governance and recommending improvements as and when necessary. |
(i) | duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole; |
(ii) | duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose; |
(iii) | directors should not improperly fetter the exercise of future discretion; |
(iv) | duty to exercise powers fairly as between different sections of shareholders; |
(v) | duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and |
(vi) | duty to exercise independent judgment. |
Individual |
Entity/Organization |
Entity’s Business |
Affiliation | |||
Josh Bayliss | Virgin Group Virgin Group Holdings Limited Corvina Holdings Limited Virgin Investments Limited Virgin Entertainment Holdings, Inc. Virgin Red Limited VGAC III |
Investment Firm Investment Firm Investment Firm Investment Firm Investment Firm Loyalty/Rewards Special Acquisition Company |
Chief Executive Officer Director Director Director Director Director Chief Executive Officer and Director | |||
Evan Lovell | Virgin Group Virgin Galactic Holdings, Inc. VO Holdings, Inc. Virgin Hotels, LLC Virgin Cruises Limited Sport Group Limited BMR Energy Ltd. BMR Energy LLC VGAC III |
Investment Firm Space Space Hospitality Travel Health & Wellness Energy Energy Special Acquisition Company |
Chief Investment Officer Director Director Director Director Director Director Director Chief Financial Officer and Director | |||
23andMe Holding Co. | Personal genomics and biotechnology | Director | ||||
Rayhan Arif | BMR Energy Virgin Mobile LATAM |
Energy Wireless Communications |
Director Director | |||
VGAC III | Special Acquisition Company | Chief Operating Officer | ||||
Latif Peracha | M13 Feelmore Labs Rho Technologies Emerge |
Venture Capital Health & Wellness FinTech Technology |
General Partner Director Director Director |
Elizabeth Nelson | Nokia Corporation Upwork Inc. Berkeley Lights Inc. |
Wireless Communications Technology Healthcare |
Director Director Director | |||
Chris Burggraeve | Vicomte LLC Seaters A.I. Toast Holdings AYR Wellness, Inc. |
Marketing Marketing Consumer Goods Medicinal |
Founder & Chief Executive Officer Director Director Director |
• | Our officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our officers is engaged in several other business endeavors for which he may be entitled to substantial compensation, and our officers are not obligated to contribute any specific number of hours per week to our affairs. |
• | Our initial shareholders hold founder shares and private placement warrants. Our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares and public shares in connection with the completion of our initial business combination. Additionally, our sponsor, officers and directors have agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares if we fail to complete our initial business combination within the prescribed time frame. If we do not complete our initial business combination within the prescribed time frame, the private placement warrants will expire worthless. Furthermore, our sponsor, officers and directors have agreed not to transfer, assign or sell any of their founder shares and any Class A ordinary shares issuable upon conversion thereof until the earlier to occur of: (i) one year after the completion of our initial business combination or (ii) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, the founder shares will be released from the lockup. |
• | The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable until 30 days following the completion of our initial business combination. Because each of our officers and directors will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. |
• | Each of Mr. Bayliss and Mr. Lovell invested $300,000 in the Sponsor and hold interests in the Sponsor that represent an indirect interest in 1,246,600 Class B ordinary shares and 197,939 private placement warrants. Mr. Arif, Mr. Burggraeve, Ms. Nelson and Mr. Peracha invested $50,000, $100,000, $100,000 and $100,000, respectively, in the Sponsor indirectly through an investment in VG Acquisition Holdings II LLC (an affiliate of the Sponsor), and hold interests in VG Acquisition Holdings II LLC that represent an indirect interest in 73,341, 70,216, 70,216 and 70,216 Class B ordinary shares, respectively, and 33,212, 66,550, 66,550 and 66,550 private placement warrants, respectively. All of such securities would be worthless if a business combination is not consummated by March 25, 2023 (unless such date is extended in accordance with our amended and restated memorandum and articles of association). |
• | Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination. |
• | each person known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares; |
• | each of our officers and directors; and |
• | all our officers and directors as a group. |
Class A ordinary shares |
Class B ordinary shares(2) |
|||||||||||||||||||
Name of Beneficial Owners(1) |
Number of Shares Beneficially Owned |
Approximate Percentage of Class |
Number of Shares Beneficially Owned |
Approximate Percentage of Class |
Approximate Percentage of Ordinary Shares |
|||||||||||||||
Citadel(3) |
2,957,800 | 7.35 | % | — | — | 5.88 | % | |||||||||||||
Millennium Management(4) |
2,612,000 | 6.49 | % | — | — | 5.19 | % | |||||||||||||
Virgin Group Acquisition Sponsor II LLC(5) |
— | — | 9,972,500 | 99.11 | % | 19.82 | % | |||||||||||||
Josh Bayliss |
— | — | — | — | — | |||||||||||||||
Evan Lovell |
— | — | — | — | — | |||||||||||||||
Rayhan Arif |
— | — | — | — | — | |||||||||||||||
Latif Peracha |
— | — | 30,000 | * | * | |||||||||||||||
Elizabeth Nelson |
— | — | 30,000 | * | * | |||||||||||||||
Chris Burggraeve |
— | * | 30,000 | * | * | |||||||||||||||
All directors and officers as a group (six individuals) |
— | * | 90,000 | * | * |
* | Less than one 1%. |
(1) | Unless otherwise noted, the business address of each of the following entities and individuals is 65 Bleecker Street, 6th Floor, New York, NY 10012. |
(2) | Interests shown consist solely of founder shares, classified as Class B ordinary shares. Such shares will automatically convert into Class A ordinary shares on the first business day following our initial business combination on a one-for-one |
(3) | The information in the table above is based solely on information contained in the Schedule 13G jointly filed on December 20, 2021 under the Exchange Act by Citadel Advisors LLC (“Citadel Advisors”), Citadel Advisors Holdings LP (“CAH”), Citadel GP LLC (“CGP”), Citadel Securities LLC (“Citadel Securities”), Citadel Securities Group LP (“CALC4”), Citadel Securities GP LLC (“CSGP”) and Mr. Kenneth Griffin (collectively with Citadel Advisors, CAH, CGP, Citadel Securities, CALC4 and CSGP, the “Citadel Parties”) with respect to our Class A ordinary shares owned by Citadel Multi-Strategy Equities Master Fund Ltd., a Cayman Islands company (“CM”), and Citadel Securities. Citadel Advisors is the portfolio manager for CM. CAH is the sole member of Citadel Advisors. CGP is the general partner of CAH. CALC4 is the non-member manager of Citadel Securities. CSGP is the general partner of CALC4. Mr. Griffin is the President and Chief Executive Officer of CGP, and owns a controlling interest in CGP and CSGP. The address of the principal business office of each of the Citadel Parties is 131 S. Dearborn Street, 32nd Floor, Chicago, Illinois 60603. |
(4) | The information in the table above is based solely on information contained in the Schedule 13G jointly filed on March 29, 2021 under the Exchange Act by Integrated Core Strategies (US) LLC (“Integrated Core Strategies”), ICS Opportunities, Ltd. (“ICS Opportunities”), Millennium International Management LP (“Millennium International Management”), Millennium Management LLC (“Millennium Management”), Millennium Group Management LLC (“Millennium Group Management”) and Israel A. Englander (“Mr. Englander”) (collectively with Integrated Core Strategies, ICS Opportunities, Millennium International Management, Millennium Management and Millennium Group Management, the “Millennium Management Parties”) with respect to our Class A ordinary shares owned by Integrated Core Strategies and ICS Opportunities. Millennium International Management is the investment manager to ICS Opportunities and may be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities. Millennium Management is the general partner of the managing member of Integrated Core Strategies and may be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies. Millennium Management is also the general partner of the 100% owner of ICS Opportunities and may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities. Millennium Group Management is the managing member of Millennium Management and may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies. Millennium Group Management is also the general partner of Millennium International Management and may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities. The managing member of Millennium Group Management is a trust of which Mr. Englander currently serves as the sole voting trustee. Therefore, Mr. Englander may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies and ICS Opportunities. The address of the principal business office of each of the Millennium Parties is 399 Park Avenue, New York, New York 10022. |
(5) | Virgin Group Acquisition Sponsor II LLC, our sponsor, is the record holder of such shares. Corvina Holdings Limited, a British Virgin Islands exempted company, is the sole managing member and manager of our sponsor, and is wholly owned by Virgin Group Holdings Limited (Virgin Group Holdings). Virgin Group Holdings is owned by Sir Richard Branson, and he has the ability to appoint and remove the management of Virgin Group Holdings and, as such, may indirectly control the decisions of Virgin Group Holdings, regarding the voting and disposition of securities held by Virgin Group Holdings. Therefore, Sir Richard Branson may be deemed to have indirect beneficial ownership of the shares held by Virgin Group Acquisition Sponsor II LLC. The address of Virgin Group Holdings Limited is Craigmuir Chambers, Road Town, Tortola, VG1110, British Virgin Islands and the address of Corvina Holdings Limited is Craigmuir Chambers, Road Town, Tortola, VG1110, British Virgin Islands. |
Page |
||||
F-2 |
||||
F-3 |
||||
F-4 |
||||
F-5 |
||||
F-6 |
||||
F-7 |
* | Filed herewith. |
Virgin Group Acquisition Corp. II | ||
By: | /s/ Josh Bayliss | |
Name: Josh Bayliss | ||
Title: Chief Executive Officer |
Name |
Position |
Date | ||
/s/ Josh Bayliss Josh Bayliss |
Chief Executive Officer (Principal Executive Officer) | February 24, 2022 | ||
/s/ Evan Lovell Evan Lovell |
Chief Financial Officer (Principal Financial and Accounting Officer) |
February 24, 2022 | ||
/s/ Rayhan Arif Rayhan Arif |
Chief Operating Officer | February 24, 2022 | ||
/s/ Latif Peracha Latif Peracha |
Director | February 24, 2022 | ||
/s/ Elizabeth Nelson Elizabeth Nelson |
Director | February 24, 2022 | ||
/s/ Chris Burggraeve Chris Burggraeve |
Director | February 24, 2022 |
Page |
||||
F-2 |
||||
F-3 |
||||
F-4 |
||||
F-5 |
||||
F-6 |
||||
F-7 to F-20 |
ASSETS: |
||||
Current Assets: |
||||
Cash |
$ | |||
Prepaid expenses |
||||
Total current assets |
||||
Prepaid expenses – non-current portion |
||||
Cash and investments held in trust account |
||||
TOTAL ASSETS |
$ |
|||
LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS’ DEFICIT |
||||
Current liabilities: |
||||
Accrued costs and expenses |
$ | |||
Due to related party |
||||
Promissory note – related party |
||||
Total current liabilities |
||||
Derivative warrant liabilities |
||||
Deferred underwriters’ discount |
||||
Total liabilities |
||||
Commitments and Contingencies (Note 7) |
||||
Class A ordinary shares, $ |
||||
Shareholders’ Deficit: |
||||
Preference shares, $ |
||||
Class B ordinary shares, $ |
||||
Additional paid-in capital |
||||
Accumulated deficit |
( |
) | ||
Total Shareholders’ deficit |
( |
) | ||
TOTAL LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS’ DEFICIT |
$ |
|||
Formation and operating costs |
$ | |||
Loss from operations |
( |
) | ||
Other income (expense) |
||||
Interest income earned on cash and investments held in trust account |
||||
Offering costs allocated to warrants |
( |
) | ||
Change in fair value of warrant liabilities |
||||
Total other income |
||||
Net income |
$ | |||
Basic and diluted weighted average shares outstanding, Class A ordinary shares |
||||
Basic and diluted net income per ordinary share, Class A ordinary shares |
$ | |||
Basic and diluted weighted average shares outstanding, Class B ordinary shares |
||||
Basic and diluted net income per ordinary share, Class B ordinary shares |
$ | |||
Class B Ordinary Shares |
||||||||||||||||||||
Shares |
Amount |
Additional Paid In Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||
Balance as of January 13, 2021 (inception) |
$ | $ | $ | $ | ||||||||||||||||
Issuance of Class B Ordinary shares to Sponsor |
||||||||||||||||||||
Accretion for Class A Ordinary Shares to redemption amount |
( |
) | ( |
) | ( |
) | ||||||||||||||
Net incom e |
— | — | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of December 31, 2021 |
$ |
$ |
$ |
( |
) |
$ |
( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities: |
||||
Net income |
$ | |||
Adjustments to reconcile net income to net cash used in operating activities: |
||||
Interest income on cash and investments held in Trust Account |
( |
) | ||
Offering costs allocated to derivative warrant liabilities |
||||
Change in fair value of derivative warrant liabilities |
( |
) | ||
Changes in operating assets and liabilities: |
||||
Prepaid assets |
( |
) | ||
Accrued costs and expenses |
||||
Due to related party |
||||
Net cash used in operating activities |
( |
) | ||
Cash Flows from Investing Activities: |
||||
Investment of cash in Trust Account |
( |
) | ||
Net cash used in investing activities |
( |
) | ||
Cash flows from financing activities: |
||||
Proceeds from purchase of Class B shares by initial shareholder |
||||
Proceeds from initial public offering, net of underwriters’ discount |
||||
Proceeds from private placement |
||||
Proceeds from notes payable—related party |
||||
Payment of offering costs |
( |
) | ||
Net cash provided by financing activities |
||||
Net change in cash |
||||
Cash, beginning of the period |
||||
Cash, end of the period |
$ | |||
Supplemental disclosure of cash flow information: |
||||
Deferred underwriting commissions charged to temporary equity |
$ | |||
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
For the period from January 13, 2021 (inception) to December 31, 2021 |
||||||||
Class A |
Class B |
|||||||
Basic and diluted net income per share: |
||||||||
Numerator: |
||||||||
Allocation of net income |
$ | $ | ||||||
Denominator: |
||||||||
Weighted-average shares outstanding including shares subject to redemption |
||||||||
Basic and diluted net income per share |
$ | $ | ||||||
Gross proceeds from IPO |
$ | |||
Less: |
||||
Proceeds allocated to Public Warrants |
( |
) | ||
Ordinary share issuance costs |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
Contingently redeemable ordinary shares |
$ |
December 31, 2021 |
Quoted Prices In Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||||||
Assets: |
||||||||||||||||
Mutual Fund held in Trust Account |
$ | $ | — | $ | — | |||||||||||
Liabilities: |
||||||||||||||||
Derivative warrant liability –Public Warrants |
$ | $ | $ | — | $ | — | ||||||||||
Derivative warrant liability –Private Warrants |
— | — | ||||||||||||||
Derivative warrant liabilities |
$ | $ | $ | — | $ | |||||||||||
December 31, 2021 |
||||
Strike price |
$ | |||
Share price |
$ | |||
Volatility |
% | |||
Risk-free rate |
% | |||
Expected term (years) |
• | in whole and not in part; |
• | at a price of $ |
• | upon not less than “30-day redemption period”) to each warrant holder; and |
• | if, and only if, the reported closing price of the Class A ordinary shares equals or exceeds $ |
Private Placement Warrants |
Public Warrants |
Warrant Liabilities |
||||||||||
Derivative warrant liabilities – initial measurement |
$ | $ | $ | |||||||||
Transfer to Level 1 |
( |
) | ( |
) | ||||||||
Change in fair value of derivative warrant liabilities |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Derivative warrant liabilities at December 31, 2021 |
$ | $ | $ | |||||||||
|
|
|
|
|
|